GGrantIndex
Sort

130,381 grants matching hiv

Penn PET Addiction Center of Excellence (Penn PACE)

$1,701,466
Robert H Mach · University Of Pennsylvania · P30 · FY2020 · DA

Consultation and Collaboration

$1,701,384
Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

NeMO Archive: SCORCH Support, Coordination and Outreach

$1,701,377
Owen R White · University Of Maryland Baltimore · UM1 · FY2025 · DA

Developmental Core

$1,701,355
Herman F. Staats · Duke University · P30 · FY2017 · AI

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group

$1,701,287
J Brooks Jackson · Social And Scientific Systems, Inc. · U01 · FY2010 · AI

Drug Design Cycle targeting HIV Protease Drug Resistance

$1,700,991
Scripps Research Institute · P01 · FY2003 · GM

High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir

$1,700,985
Jonathan Li · Brigham And Women'S Hospital · P01 · FY2025 · AI

Studies of HIV infection and its contribution to the natural history and outcome

$1,700,139
Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA

PROVISION OF MEDICAL MALE CIRCUMSION FOR HIV PREVENTION IN THE REPUBLIC OF SOUTH

$1,700,000
Kelly Curran · Johns Hopkins University · U2G · FY2011 · GH

GH11-1191: IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES

$1,700,000
Jean William Pape · Gheskio Center · U2G · FY2015 · GH

California-Arizona Clinical Trials Network Node

$1,700,000
University Of California San Francisco · U10 · FY2002 · DA

HIV VACCINE DESIGN AND DEVELOPMENT TEAMS FOR PREVENTION AND TREATMENT

$1,700,000
Susan W Barnett · · N01 · FY2007 · AI

HIV Vaccine Design and Development, Part A-Preventative Vaccines

$1,700,000
· N01 · FY2007 · AI

Miami Womens Interagency HIV Study WIHS

$1,699,999
Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2013 · AI

HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular Disease

$1,699,969
Allison Michelle Andrews · University Of Florida · DP2 · FY2022 · DA

University of Cincinnati AIDS Clinical Trials Unit- UC ACTU

$1,699,965
Carl J Fichtenbaum · University Of Cincinnati · U01 · FY2008 · AI

A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail

$1,699,618
Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2019 · DA

Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination

$1,699,333
Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2014 · AI

AIDS CLINICAL TRIALS UNIT

$1,699,170
Harvard University (Medical School) · U01 · FY2002 · AI

Providence/Boston Center for AIDS Research (CFAR)

$1,699,116
Susan Cu-Uvin · Miriam Hospital · P30 · FY2024 · AI

Imaging Studies in Neurotoxicity and Neurodevelopment

$1,698,995
Linda Chang · University Of Hawaii At Manoa · U54 · FY2007 · NS

Project 1: Establishing a robust functional cure

$1,698,874
Mauricio De Aguiar Martins · Boston Children'S Hospital · U19 · FY2024 · AI

Minority Biomedical Career Enhancement at Cal State LA

$1,698,489
Carlos Gabriel Gutierrez · California State University Los Angeles · R25 · FY2007 · GM

The origin, predictors, and immune correlates of viral rebound in orally SHIV infected infant monkeys

$1,698,360
Sallie R. Permar · Duke University · P01 · FY2017 · AI

Johns Hopkins AIDS Clinical Trials Unit

$1,698,051
Charles W. Flexner · Johns Hopkins University · UM1 · FY2012 · AI